

Struggling to find Difluprednate (Durezol) at your pharmacy? Use these tools and tips to locate Difluprednate in stock near you in 2026.
Your eye doctor wrote the prescription. Now you just need to fill it. Simple, right?
Not in 2026. Difluprednate — the potent corticosteroid eye drop sold as Durezol — has been in short supply since early 2024. If you've been turned away from your pharmacy (or multiple pharmacies), this guide will show you exactly how to track down Difluprednate in stock near you.
The good news: it is still available. You just need to know where to look and how to search efficiently.
The fastest way to find Difluprednate is to use Medfinder. It searches pharmacies near your location and shows you which ones currently have Difluprednate in stock — no calling around required.
Here's how it works:
This is especially useful during a shortage like the current one, where availability changes quickly. Learn more about checking pharmacy stock for Difluprednate.
When a drug is in shortage, chain pharmacies (CVS, Walgreens, Rite Aid) tend to run out first because they serve the highest volume of patients. Independent pharmacies often have better luck sourcing medications through different wholesale channels.
Here's why independent pharmacies can be your best bet:
Don't be afraid to call smaller, locally owned pharmacies. They're often more resourceful during shortages.
Pharmacies receive their shipments on specific days, and knowing when to call can improve your chances.
If you've exhausted your local options, here are additional steps:
Your eye doctor may be able to switch you to an alternative steroid eye drop that's more readily available. Common alternatives include Prednisolone Acetate (Pred Forte), Loteprednol Etabonate (Lotemax), and Dexamethasone (Maxidex). Read our full guide on alternatives to Difluprednate.
Ophthalmology offices often know which local pharmacies are stocking Difluprednate. Some practices even keep samples or have relationships with specialty pharmacies. Don't hesitate to call your doctor's office and ask for help locating the medication.
Mail-order pharmacies and specialty pharmacy services may have access to supply that local retail pharmacies don't. If you have a few days before you absolutely need the medication, this can be a viable option. Just make sure to plan ahead — shipping usually takes 3–5 business days.
Sometimes the medication is technically available but the cost is the real barrier. Brand-name Durezol can run $250 to $400 per bottle. If that's what's standing in your way, check out our guide to saving money on Difluprednate, including coupons, discount cards, and patient assistance programs that can bring the price as low as $43.
Understanding the shortage can help you plan better. The current Difluprednate shortage began in April 2024 when generic manufacturer Exelan placed its product on indefinite back order. With limited generic producers in the market, supply has struggled to keep up with the steady demand from millions of annual cataract surgeries and uveitis treatments.
For the full story, read our detailed explainer on why Difluprednate is so hard to find.
Finding Difluprednate in 2026 takes a little more effort than usual, but it's absolutely possible. Start with Medfinder to check real-time availability, branch out to independent pharmacies, and time your search strategically. If all else fails, your ophthalmologist can help you explore alternatives or connect you with specialty pharmacy resources.
Your eye health is too important to leave to chance. Stay proactive, use the right tools, and you'll find what you need.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.